Phase I study of recombinant human CD40 ligand in cancer patients.
Vonderheide RH, Dutcher JP, Anderson JE, Eckhardt SG, Stephans KF, Razvillas B, Garl S, Butine MD, Perry VP, Armitage RJ, Ghalie R, Caron DA, Gribben JG.
Vonderheide RH, et al.
J Clin Oncol. 2001 Jul 1;19(13):3280-7. doi: 10.1200/JCO.2001.19.13.3280.
J Clin Oncol. 2001.
PMID: 11432896
Clinical Trial.